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Parathyroid carcinoma is a rare endocrine malignancy, accounting for less than 1% of cases of primary
hyperparathyroidism. Patient-related factors such as age and sex, as well as the biological features and
management of the cancer, influence mid-term and long-term survival. We report a case of a young man with an
unusual presentation of parathyroid carcinoma. The patient presented with left thigh swelling, which had been
present for 6 months without other symptoms of hypercalcemia. On computed tomography scan a hypodense
lesion, 30 × 20 × 20 mm in size, was seen in the posterior thyroid. There was no evidence of cervical
lymphadenopathy or local infiltration. On a Sestamibi scan, a hot spot was seen in the lower pole of left thyroid
lobe. Cervical neck exploration was performed. The patient subsequently underwent surgery and a parathyroid
tumor was excised. The tumor was adherent to the thyroid capsule, but there was no evidence of invasion. After
surgery, the patient’s calcium and parathyroid hormone levels normalized, but histology confirmed parathyroid
carcinoma with capsular and vascular invasion. The patient was offered reoperation, but declined, and developed
recurrent parathyroid carcinoma 2 years later. In this report, we aim to present the challenges in managing
parathyroid carcinoma and discuss factors that might contribute to future locoregional recurrences. This case also
highlighted several issues, including the challenge of ascertaining the diagnosis before surgery and the dilemma of
reoperation after simple excision.
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Parathyroid carcinoma (PC) is a rare endocrine malig-
nancy, accounting for less than 1% of cases of primary
hyperparathyroidism [1,2]. In addition, PC is a rare endo-
crine-related malignancy prone to locoregional recurrence
(LRR), despite curative resection [1,2]. Age, sex, histopa-
thologic features and type of resection have all been
shown to influence LRR [3]. In this report, we aim to
present the challenges in managing PC, and discuss some
factors that might contribute to future LRR.Case presentation
A 30-year-old man presented with a 6-month history of
non-traumatic swelling in his left thigh. Radiography of
the left femur showed an osteolytic mid-shaft lesion
without any fracture. There were no other symptoms* Correspondence: blang@hkucc.hku.hk
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reproduction in any medium, provided the orsuch as weakness, fatigue, nausea, vomiting, constipa-
tion, dyspepsia, headache, polyuria, or abdominal pain.
Laboratory investigations showed that the patient had
raised levels of adjusted calcium (3.55 mmol/l; normal
range 2.24 to 2.63 mmol/l), phosphate (0.44 mmol/l; nor-
mal range 0.88 to 1.43 mmol/l) and parathyroid hormone
(PTH) (2,187 pg/ml; normal range 10 to 66 pg/ml).
On clinical examination, a small mass was palpable over
the left thyroid gland. Sestamibi scan showed a hot spot
localized in the left mid-pole of the thyroid (Figure 1). On
a computed tomography (CT) scan of the neck, a hypo-
dense lesion, 30 × 20 × 20 mm in size was seen in the
posterior the thyroid, without cervical lymphenopathy or
local infiltration (Figure 2). Cervical neck exploration was
performed subsequently. The patient underwent surgery,
during which a large parathyroid tumor measuring 45 ×
30 × 25 mm and weighing about 15 g was excised. The
tumor was adherent to the thyroid capsule, but there was
no evidence of invasion. An intra-operative parathyroid
hormone (IOPTH) assay showed a drop of 90% in PTHl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 A delayed image (2.5 hours) of the Sestamibi scans. There was focal retention of tracer over the left middle or lower pole of the
thyroid (arrow).
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gland. After the operation, the patient’s calcium and PTH
levels normalized, but histology confirmed PC with capsu-
lar and vascular invasion (Figure 3). In view of this, the
patient was offered reoperation, but he refused and did
not attend for follow-up.
Two years later, the patient re-presented. He was
found to have palpable neck swelling, and laboratory in-
vestigations showed hypercalcemia and raised PTH. An
ipsilateral lobectomy and central lymph-node dissection
were performed. IOPTH once again showed a drop in
PTH (this time of more than 50%) 10 minutes after the
procedure. The histology results confirmed recurrent
PC, but all six lymph nodes were negative for metastasis.
The patient’s serum calcium and PTH level normalized
after the second operation. He received a course ofFigure 2 (a,b). Axial computed tomography scan of the neck. A hypod
thyroid (arrow) without cervical lymphadenopathy or local infiltration.external radiotherapy, and has remained disease-free
during a follow-up period of 18 months.
Discussion
Unlike parathyroid adenoma, PC affects both sexes
equally, and patients are around 10 years younger than
those with parathyroid adenoma [4]. The current patient
was a man in his early 30s, which is not the typical pres-
entation of PC. In a recent study of 330 patients, male
sex, young age, and higher calcium levels were adverse
clinical prognostic factors, thus based on this, our
patient would be considered at high risk [3,5].
This case highlights several issues, including the
challenge of ascertaining the diagnosis of PC before sur-
gery, and the dilemma of reoperation after simple exci-
sion. It is difficult to differentiate PC from adenoma, andense lesion 30 × 20 × 20 mm in size was visible in the posterior
Figure 3 (a,b). Vascular invasion by the tumor cells. Hematoxylin and eosin, original magnification (a) ×10; (b) ×40.
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comes [2]. The criteria proposed by Schantz and
Castleman seem to be the key features distinguishing
carcinoma from benign counterparts. These include a
trabecular pattern, mitotic figures, thick fibrous bands,
and capsular and blood-vessel invasion [2,6]. Fine-needle
aspiration cytology would not be able to distinguish aden-
oma from carcinoma, as the diagnosis requires histological
morphology and criteria [7]. Although extremely high
PTH and calcium level (>3.5 mmol/L) may be the first in-
dication of malignancy, a wide overlap between benign
and malignant tumors has been reported [8]. In our case,
the PTH level was extremely high, but the patient’s symp-
toms and calcium level were not suggestive of malignancy.
Other features such as osteitis fibrosa cystica, a palpable
neck mass, a high depth:width ratio on ultrasonography
and CT tomography are important features of PC [2].
Based on the scintigraphy and IOPTH assay, removal
of the parathyroid tumor in this case was successful. Al-
though more than 90% of PCs are functional and scintig-
raphy may be a valid tool for tumor localization, it tends
to fail in localizing LRR and metastases [9]. In addition,
the role of IOPTH in managing PC is still doubtful, even
though it has been proven as an effective and safe
method for the treatment of primary hyperparathyroid-
ism [10]. Although en bloc resection is often recom-
mended for PC, it is possible only in 10 to 15% of cases
because ascertaining the diagnosis of PC is difficult and
requires a high index of suspicion [2]. In this case, we
performed an en bloc resection with ipsilateral lobec-
tomy for the second operation, as the choice of surgical
procedures significantly influences the outcome. Carry-
ing out local excision only compared with any form of
wider excision carries a risk 1.5-fold to 2-fold higher for
recurrence and death both at 5 years and overall [3].
Conclusion
PC is a very rare disease and making the diagnosis of PC
is often difficult. This leads to delayed diagnosis when
the tumor is already palpable. In addition, prognosis isnot predictable because after the malignancy is con-
firmed, recurrences occur in most cases. In the setting
of a suspected PC, neck exploration must be performed
with an en bloc resection of the tumor with ipsilateral
thyroid lobectomy. A high index of suspicion and a
moderate enhancement of the surgical approach inclu-
ding systemic central node dissection may improve the
outcome for PC.
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